Time period:January 15, 2019-March 30, 2020
Customer introduction:Customer makes mental health products. On January 15, 19, the project started with 98% icaritin. The single cost of icaritin was too high and it was one of the important ingredients that could not be replaced, resulting in product pricing that did not meet their expectations.
Customer requirements: It is required to reduce the cost of raw materials of epimedium, and try to reduce the content of icariin, because the appearance of icariin in males will affect the finished product.
Final results: The experimental results will be finalized on March 30, 2020. 60% icaritin, the price is 30% of the original 98%, and the content of icaritin is not detected (the detection limit is 0.01%).Our customer was satisfied with this result we build long term cooperation.
If you are interested in our epimedium product series, you can click here to view.